(NASDAQ: IVA) Inventiva Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 43.76%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.65%.
Inventiva Sa's earnings in 2025 is -$361,703,488.On average, 8 Wall Street analysts forecast IVA's earnings for 2025 to be -$120,658,974, with the lowest IVA earnings forecast at -$200,623,166, and the highest IVA earnings forecast at -$18,080,192. On average, 8 Wall Street analysts forecast IVA's earnings for 2026 to be -$95,174,513, with the lowest IVA earnings forecast at -$219,372,995, and the highest IVA earnings forecast at -$37,164,839.
In 2027, IVA is forecast to generate -$106,921,854 in earnings, with the lowest earnings forecast at -$276,559,972 and the highest earnings forecast at -$48,213,845.